Rocket Lab: Do You Like To Buy Expensive, Overvalued Things? (Archive) Rocket Lab’s rich valuation masks near-term growth hiccups and only modest upside catalysts.
Petrobras: My Top Bet For Positive Returns In A Market-Wide Correction (Archive) Petrobras: low-cost oil powerhouse poised to outperform in a market-wide correction.
Allot: Too Overhyped To Make Buys Worthwhile (Archive) Allot’s growth story remains unproven, with flat revenues, slowing SECaaS momentum and stretched valuations.
Why Zeta's Weak Revenue Guidance Should Worry You (Archive) Zeta’s revenue, profitability and technicals flash downside risk despite cheaper valuations.
Range Resources: Don't Miss The Boat On This Natural Gas Play (Archive) Efficient natural gas operator poised to ride data center demand and bullish price tailwinds.
Realty Income: Don't Be Fooled By Discount Valuations (Archive) Muted AFFO growth and rising provisions overshadow Realty Income’s tempting valuation discount.
Nebius Group: One Big Reason To Rethink The Buys (Archive) Nebius' cash burn, pricing pressures, and rich valuation temper the high-growth narrative.